Why Pharmaceutical Companies Rely on GLP Labs for Preclinical Testing
Pharmaceutical drug development requires verifiable safety data before clinical trials can begin in humans. Regulatory agencies enforce strict Good Laboratory Practice standards to guarantee data reproducibility and study quality. Sponsor organizations must present fully compliant preclinical packages during Investigational New Drug submissions. Working alongside certified facilities ensures that nonclinical safety assessments withstand detailed regulatory reviews. […]
English